Literature DB >> 856005

Antimicrobial susceptibilities of Yersinia enterocolitica biotype 4, serotype O:3.

S Hammerberg, S Sorger, M I Marks.   

Abstract

Agar dilution antimicrobial susceptibility tests were carried out against recent clinical isolates of Yersinia enterocolitica biotype 4, serotype O:3. Aminoglycosides and co-trimoxazole were the most active drugs. All isolates were resistant to ampicillin, carbenicillin, cloxacillin, and erythromycin.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 856005      PMCID： PMC352022          DOI： 10.1128/AAC.11.3.566

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  3 in total

1.  An improved single-disk method for testing the antibiotic susceptibility of rapidly-growing pathogens.

Authors:  A L Barry; F Garcia; L D Thrupp
Journal:  Am J Clin Pathol       Date:  1970-02       Impact factor: 2.493

2.  Influences of media and inocula on the in vitro susceptibility of Haemophilus influenzae to co-trimoxazole, ampicillin, penicillin, and chloramphenicol.

Authors:  M I Marks; G Weinmaster
Journal:  Antimicrob Agents Chemother       Date:  1975-12       Impact factor: 5.191

3.  Survey on the incidence of Yersinia enterocolitica infection in Canada.

Authors:  S Toma; L Lafleur
Journal:  Appl Microbiol       Date:  1974-09
  3 in total
  10 in total

1.  Common bacterial infections in infancy and childhood. 6. Enteric infections.

Authors:  M I Marks
Journal:  Drugs       Date:  1978-09       Impact factor: 9.546

2.  Yersinia enterocolitica: comparative in vitro activities of seven new beta-lactam antibiotics.

Authors:  R K Scribner; M I Marks; A Weber; C H Pai
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

3.  Yersinia enterocolitica: in vitro antimicrobial susceptibility.

Authors:  M Raevuori; S M Harvey; M J Pickett; W J Martin
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

4.  In vitro antimicrobial susceptibilities of Yersinia enterocolitica and related species isolated from slaughtered pigs and pork products.

Authors:  J Kwaga; J O Iversen
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

5.  Yersiniosis in children.

Authors:  M Mäki; T Vesikari; I Rantala; P Grönroos
Journal:  Arch Dis Child       Date:  1980-11       Impact factor: 3.791

6.  Antimicrobial susceptibility of pathogenic Yersinia enterocolitica isolated in Canada from 1972 to 1990.

Authors:  M A Preston; S Brown; A A Borczyk; G Riley; C Krishnan
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

7.  HeLa cell infection by Yersinia enterocolitica: evidence for lack of intracellular multiplication and development of a new procedure for quantitative expression of infectivity.

Authors:  J A Devenish; D A Schiemann
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

8.  In vitro susceptibilities of 126 clinical isolates of Yersinia enterocolitica to 21 beta-lactam antibiotics.

Authors:  M J Hornstein; A M Jupeau; M R Scavizzi; A M Philippon; P A Grimont
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

Review 9.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

10.  Yersinia enterocolitica, a Neglected Cause of Human Enteric Infections in Côte d'Ivoire.

Authors:  Daniel Saraka; Cyril Savin; Stephane Kouassi; Bakary Cissé; Eugène Koffi; Nicolas Cabanel; Sylvie Brémont; Hortense Faye-Kette; Mireille Dosso; Elisabeth Carniel
Journal:  PLoS Negl Trop Dis       Date:  2017-01-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.